O'Brien Federica F. 4
4 · TELA Bio, Inc. · Filed Jun 6, 2024
Insider Transaction Report
Form 4
TELA Bio, Inc.TELA
O'Brien Federica F.
Director
Transactions
- Award
Common Stock
[F1]2024-06-04+4,250→ 10,520 total - Award
Stock Option (Right to Buy)
[F2]2024-06-04+6,200→ 6,200 totalExercise: $5.71Exp: 2034-06-04→ Common Stock (6,200 underlying)
Footnotes (2)
- [F1]These restricted stock units vest on the earlier of (a) June 4, 2025, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.
- [F2]The option vests on the earlier of (a) June 4, 2025, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.
Signature
/s/ Megan Smeykal, Attorney-in-fact|2024-06-06